BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28269763)

  • 1. Development of high-affinity monoclonal antibody using CD44 overexpressed cells as a candidate for targeted immunotherapy and diagnosis of acute myeloid leukemia.
    Amanzadeh A; Heidarnejad F; Abdollahpour-Alitappeh M; Molla-Kazemiha V; Yari S; Hadizadeh-Tasbiti A; Habibi-Anbouhi M; Abolhassani M; Shokrgozar MA
    Hum Antibodies; 2017; 26(1):7-15. PubMed ID: 28269763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a new anti-CD123 monoclonal antibody to target the human CD123 antigen as an acute myeloid leukemia cancer stem cell biomarker.
    Abdollahpour-Alitappeh M; Razavi-Vakhshourpour S; Abolhassani M
    Biotechnol Appl Biochem; 2018 Nov; 65(6):841-847. PubMed ID: 29972607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of a peptide-based monoclonal antibody against CD44 variant 6.
    Zarei S; Bayat AA; Hadavi R; Mahmoudi AR; Tavangar B; Vojgani Y; Jeddi-Tehrani M; Amirghofran Z
    Monoclon Antib Immunodiagn Immunother; 2015 Feb; 34(1):36-43. PubMed ID: 25723282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and characterization of a high-affinity monoclonal antibody for MUC1 measurement in breast cancer.
    Hamid SS; Cheah SH
    Hybridoma (Larchmt); 2011 Apr; 30(2):137-43. PubMed ID: 21529286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of monoclonal antibodies against human IgA in Balb/c mice.
    Ezzatifar F; Majidi J; Baradaran B; Maleki LA; Abdolalizadeh J; Yousefi M
    Hum Antibodies; 2014; 23(1-2):7-12. PubMed ID: 25812697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of a hybridoma cell line secreting retinoic acid-specific monoclonal antibody.
    Zhou HR; Abouzied MM; Zile MH
    J Immunol Methods; 1991 Apr; 138(2):211-23. PubMed ID: 2033274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obtaining and characterization of monoclonal antibodies against recombinant extracellular domain of human epidermal growth factor receptor 2.
    Sarina N; Abeldenov S; Turgimbayeva A; Zhylkibayev A; Ramankulov Y; Khassenov B; Eskendirova S
    Hum Antibodies; 2018 Feb; 26(2):103-111. PubMed ID: 29036807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of monoclonal antibody against a triple negative breast cancer cell line.
    Ghaderi F; Ahmadvand S; Ramezani A; Montazer M; Ghaderi A
    Biochem Biophys Res Commun; 2018 Oct; 505(1):181-186. PubMed ID: 30243716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of murine monoclonal antibody against synthetic peptide of CD34.
    Maleki LA; Majidi J; Baradaran B; Abdolalizadeh J; Akbari AM
    Hum Antibodies; 2013; 22(1-2):1-8. PubMed ID: 24284303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and identification of monoclonal antibody against abrin-a.
    Li XB; Yang W; Zhang Y; Zhang ZG; Kong T; Li DN; Tang JJ; Liu L; Liu GW; Wang Z
    J Agric Food Chem; 2011 Sep; 59(18):9796-9. PubMed ID: 21870856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obtaining and characterization of anti-testis monoclonal antibodies: Invaluable tools toward the identification of testis antigens involved in fertilization.
    Hemati A; Azarnia M; Hossein Modarressi M; Rahimi A
    Hum Antibodies; 2018; 26(4):209-218. PubMed ID: 29889062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation and characterization of monoclonal antibodies against human laminin].
    Yao MJ; Huang HC; You LX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):84-5. PubMed ID: 15132917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of a new monoclonal antibody against CXCR4 using lentivirus vector.
    Li X; Kuang Y; Huang X; Zou L; Huang L; Yang T; Li W; Yang Y
    Int Immunopharmacol; 2016 Jul; 36():100-105. PubMed ID: 27124560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of a panel of monoclonal antibodies specific for human fibroblast growth factor receptor 4 (FGFR4).
    Chen C; Patel S; Corisdeo S; Liu X; Micolochick H; Xue J; Yang Q; Lei Y; Wang B; Soltis D
    Hybridoma (Larchmt); 2005 Jun; 24(3):152-9. PubMed ID: 15943563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.
    Yang LJ; Wang WL
    World J Gastroenterol; 2002 Oct; 8(5):808-14. PubMed ID: 12378620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and preliminary application of monoclonal antibodies to the receptor binding region of Clostridium difficile toxin B.
    Chen W; Liu WE; Li YM; Luo S; Zhong YM
    Mol Med Rep; 2015 Nov; 12(5):7712-20. PubMed ID: 26459027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of monoclonal antibodies against human CD20 in Balb/c mice.
    Sepehr KS; Baradaran B; Majidi J; Abdolalizadeh J; Aghebati L; Shahneh FZ
    Hum Antibodies; 2012; 21(3-4):57-64. PubMed ID: 23549022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation and characterization of monoclonal antibody against Enterohemorrhagic Escherichia coli O157:H7 EspA].
    Yu S; Luo P; Chen HZ; Li HX; Mao XH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):657-9. PubMed ID: 17618593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.